Patent ID: 8501794

Claim:
A compound selected from the group consisting of: neopentyl (5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidenecarbamate; 2,2,2-trichloroethyl (5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidenecarbamate; 1-adamantyl (5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidenecarbamate; N 2 -({[(5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidene]amino}carbonyl)-N 1 -3-dimethyl-L-valinamide; and N-[(5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidene]-N′-(4-methylcyclohexyl)urea; or a pharmaceutically acceptable salt thereof.